Superpotent topical steroid therapy for epidermolysis bullosa acquisita [6]

Dermatology

Volumn 209, Issue 2, 2004, Pages 164-166

  Abecassis, S ^a   Joly, P ^c   Genereau, T ^b   Courville, P ^c   Andre C ^d   Moussalli, J ^a   Chosidow, O ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c UNIVERSITÉ DE ROUEN   (France)

^d HENRI MONDOR HOSPITAL   (France)

Author keywords

Epidermolysis bullosa acquisita; Topical steroids; Viral C hepatitis

Indexed keywords

ALPHA INTERFERON; CLOBETASOL PROPIONATE; PREDNISOLONE 3 SULFOBENZOATE; RIBAVIRIN;

ADULT; ANAMNESIS; CASE REPORT; DISEASE ASSOCIATION; DISEASE COURSE; DRUG POTENCY; EPIDERMOLYSIS BULLOSA ACQUISITA; FEMALE; HEPATITIS C; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LABORATORY TEST; LETTER; PRIORITY JOURNAL; SEROLOGY;

EID: 4444343892     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079608     Document Type: Letter

References (11)

1. Fine JD: Management of acquired bullous skin diseases. N Engl J Med 1995;333:1475-1484.
2. Gammon WR, Briggaman RA, Woodley DT, Heald PW, Wheeler CE Jr: Epidermolysis bullosa acquisita: A pemphigoid-like disease. J Am Acad Dermatol 1984;11:820-832.
3. Joly P, Gilbert D, Thomine E, Delpech A, Courville P, Young P, Le Corvaisier C, Lauret P, Tron F: Relationship between the in vivo localization and the immunoblotting pattern of anti-basement membrane zone antibodies in patients with bullous pemphigoid. Arch Dermatol 1997;133:719-724.
4. Thiery S, Misery L, Chossegros P, Kanitakis J, Ghohestani R, Forest JY, Trepo C, Faure M, Claudy A: Epidermolysis bullosa acquisita and hepatitis C. Ann Dermatol Venereol 1998;125:264-267.
5. Magy N, Cribier B, Schmitt C, et al: Effects of corticosteroids on HCV infection. Int J Immunopharmacol 1999;21:253-261.
6. Calleja JL, Albillos A, Cacho G, Iborra J, Abreu L, Escartin P: Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies. J Hepatol 1996;24:308-312.
7. Funaoka M, Kato K, Komatsu M, Ono T, Hoshino T, Kato J, Kuramitsu T, Ishii T, Toyoshima I, Masamune O: Fulminant hepatitis caused by hepatitis C virus during treatment for multiple sclerosis. J Gastroenterol 1996;31:119-122.
8. Choi GS, Lee ES, Kim SC, Lee S: Epidermolysis bullosa acquisita localized to the face. J Dermatol 1998;25:19-22.
9. Westerhof W: Treatment of bullous pemphigoid with topical clobetasol propionate. J Am Acad Dermatol 1989;20:458-461.
10. Guillaume JC, Donnard JC, Schnebelen MP, Tortel MC, Michel C, Grange F: Local corticosteroid therapy in a severe form of pemphigoid gestationis. Ann Dermatol Vénéréol 1996;123:31.
11. Joly P, Roujeau JC, Benichou J, Picard C, Dreno B, Delaporte E, Vaillant L, D'Incan M, Plantin P, Bedane C, Young P, Bernard P: The Bullous Diseases French Study Group: A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med 2002;346:321-327.